DFM STUDENT SYLLABUS - Flipbook - Page 28
Interpreting Combined IgG and IgA Results
418
Symptom Correlation
418
Comparison with Traditional Food Sensitivity Testing
418
Traditional IgG Testing Limitations
418
ELISA Technology Advancements
419
Clinical Validation Studies
419
Limitations and Considerations
419
Testing Limitations
419
Clinical Context Integration
420
Implementation Challenges
420
Recommended Testing Frequency and Monitoring
421
Initial Testing Considerations
421
Follow-up Testing Timelines
421
Monitoring Clinical Progress
421
Patient Preparation for Array 10 Testing
422
Dietary Considerations
422
Medication and Supplement Adjustments
422
Sample Collection Protocols
423
Documentation and History
423
Case Application: Clinical Example
423
Patient Profile
424
Initial Assessment
424
Array 10 Findings
424
Intervention Protocol
424
Outcome and Follow-up
425
Future Research Directions
425
Emerging Technologies
425
Clinical Research Priorities
426
Personalized Medicine Applications
426
Conclusion: The Future of Food Immune Reactivity Testing
426
References
427
Array 10-90 4 Multiple Food Immune Reactivity Screen
438
Simplified Detection of Food-Driven Inflammation and Immune Activation 438
27
